Search
  1. Home
  2. East Africa
  3. Uganda
  • News

HIV vaccine trials still on

    JOHANNESBURG
    Phase-one trials for an HIV vaccine will proceed, despite the drop-out of two volunteers, the Uganda Virus Research Institute (UVRI) said on Friday. UVRI on Monday announced the launch of trials for a vaccine which targets the HIV subtype A, found to be most prevalent in East Africa. "Research of this importance should always be well planned for. The two women who dropped out of the vaccine trials will be replaced without hassle," URVI's head of immunology, Dr. Pontiano Kaleebu, told the UN news service PlusNews. Kaleebu said while only 50 volunteers were selected to participate in the vaccine trials, UVRI had screened 300 people for the event of minor obstacles such as this. "The two volunteers dropped out before being administered the first series of injections," Kaleebu added.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join